BAP1 loss predicts longer survival for mesothelioma patients treated with pemetrexed-based chemotherapy
Vasiliki Panou, Amber Louw, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Louise Lynggård Andersen, Azadeh Birbaneh Asghari, Mogens Vyberg, Johnni Hansen, Jenette Creaney, Oluf Dimitri Røe
European Respiratory Journal Sep 2020, 56 (suppl 64) 4490; DOI: 10.1183/13993003.congress-2020.4490